People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Other Health Care, Healthtech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ablative Solutions, Inc. | — | Other Health Care | Series C | $180.2M | $59.8M | 2018 |
| Alleviant Medical, Inc. | — | Healthtech | Series C | $148.8M | $677.4M | 2024 |
| TearScience, Inc. | — | Pharmaceuticals | Series B | $58.9M | $653.7M | 2010 |
| Inova Labs, Inc. | — | Other Health Care | Series A | $32.6M | $302.7M | 2011 |
Geoff R. Pardo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Geoff R. Pardo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian R. Smith | 1 | 21 |
| Joel Cutler | 1 | 16 |
| Kirk Nielsen | 1 | 13 |
| Ashok Gowda | 1 | 12 |
| Todd Davis | 1 | 8 |
| Immanuel Thangaraj | 1 | 6 |
| Christopher Kaster | 1 | 5 |
| Joe Mandato | 1 | 5 |
| Tim A Fischell | 1 | 4 |
| Phillip D. Torrence | 1 | 4 |
| Adam Berman | 1 | 4 |
| Abhijeet Lele | 1 | 3 |
| RODERICK A. YOUNG | 1 | 3 |
| Maria Berkman | 1 | 3 |
| David R. Fischell | 1 | 3 |
| H. David Shockley | 1 | 2 |
| Paul L. Buckman | 1 | 2 |
| Paul R. Buckman | 1 | 2 |
| Stephen M. Salmon | 1 | 2 |
| David K. Rosen | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.